Silencing of retroviruses in the human genome is a crucial step in the production of induced pluripotent stem cells (iPSCs) from somatic cells. Researchers led by a team from the University of Tsukuba have now identified a protein that controls retrovirus silencing, allowing the production of high quality iPSCs that could be used in applications ranging from stem cell therapy and organ regeneration to drug discovery.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023